GPS Wealth Strategies Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

GPS Wealth Strategies Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-205	Closed	-$14.9K	–	1294
2023 Q3	$14.9K	Hold	205	–	–	﹤0.01%	756
2023 Q2	$15.5K	Buy	205 +1	+0.5%	+$76	﹤0.01%	752
2023 Q1	$15.5K	Buy	+204	New	+$15.7K	﹤0.01%	749
2022 Q4	–	Sell	-203	Closed	-$14K	–	815
2022 Q3	$14K	Buy	+203	New	+$15.1K	﹤0.01%	697

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

GPS Wealth Strategies Group's PJP Position: Q4 2023 in Review

GPS Wealth Strategies Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2023, closing a stake of 205 shares — an estimated $14.9K sold.

GPS Wealth Strategies Group first reported a position in PJP in Q3 2022 and held it in 4 quarters. The position peaked at $15.5K in Q1 2023. 86 funds tracked by Wall St. Rank hold PJP as of Q4 2023.

GPS Wealth Strategies Group reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2023 after selling out during the quarter.
GPS Wealth Strategies Group sold 205 Invesco Pharmaceuticals ETF shares in Q4 2023, an estimated $14.9K.
GPS Wealth Strategies Group first reported a position in Invesco Pharmaceuticals ETF in Q3 2022 and held it in 4 quarters.
GPS Wealth Strategies Group's Invesco Pharmaceuticals ETF position peaked at $15.5K in Q1 2023.
86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2023.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2023, filed 12 Jan 2024.